Institut Bergonié clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 119 studies whose lead sponsor is Institut Bergonié. 16 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Keep track of what changes. Save the Institut Bergonié studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- France
- 111
Focus areas
Conditions Institut Bergonié leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 119. Browse all 119 →
- Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate CancerRecruitingNCT05346848Phase 2
- Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase TrialsRecruitingNCT02534649Not applicable
- CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.RecruitingNCT02789384Not applicable
- Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast CancerRecruitingNCT07614620Not applicable
- Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic AdenocarcinomaRecruitingNCT06705335
- Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.Not yet recruitingNCT07425548Not applicable
- Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.RecruitingNCT06700057
- Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung AdenocarcinomaRecruitingNCT04339218Phase 3
- Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle TumoursRecruitingNCT06540846
- Combination of Pembrolizumab and Cabozantinib in Patients With Advanced SarcomasRecruitingNCT05182164Phase 2
- Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue SarcomasRecruitingNCT03805022Phase 3
- High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU StudyRecruitingNCT03342625Not applicable
- Bergonie Institute Breast Cancer DatabaseRecruitingNCT02893761
- National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma GroupRecruitingNCT03978039
- MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.Not yet recruitingNCT05888857Phase 2
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised ManagementCompletedNCT05415527Not applicable
- Streamlined Geriatric and Oncological Evaluation Based On IC TechnologyActive, not recruitingNCT05720910Not applicable
- Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)Active, not recruitingNCT04968106Phase 2
- Remote Monitoring for Ambulatory Care of Elderly Patients With CancerCompletedNCT04913259Not applicable
- Circulating Tumor DNA After Neoadjuvant ChemotherapyCompletedNCT03357120Not applicable
- Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer SurgeryCompletedNCT04906187Not applicable
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized StudyActive, not recruitingNCT04258137Not applicable
- Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced SarcomaActive, not recruitingNCT04874311Phase 2
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2
- Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN GeneSuspendedNCT05630105
- Targeting ATR in Soft-tissue SarcomasCompletedNCT04807816Phase 2
- Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyCompletedNCT04095208Phase 2
- Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer OriginTerminatedNCT03960021Not applicable
- Combining Epigenetic And Immune Therapy to Beat Cancer.CompletedNCT04705818Phase 2
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsCompletedNCT04008238Not applicable
- Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC PatientsCompletedNCT04912687Not applicable
- Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer PatientsTerminatedNCT04880382Phase 2
- A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue SarcomaCompletedNCT02787642Phase 1
- Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and OverActive, not recruitingNCT03077178Not applicable
- Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic CyclophosphamideCompletedNCT02805725Phase 1/2
- Role of FCγRIIIA and FCγRIIA Receptor PolymorphismsCompletedNCT01827956
- Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)CompletedNCT03963544
- Patterns of Care and Outcomes in Patients With Metastatic Bone Tumors (METABONE)CompletedNCT03963531
- Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life DatabasesCompletedNCT03676257
- Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)Active, not recruitingNCT03676010
- Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II TrialCompletedNCT02406781Phase 2
- Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)CompletedNCT03359759
- Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast CancerTerminatedNCT00210236Phase 3
- A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK StudyCompletedNCT04010240
- Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / UltrasoundCompletedNCT02819362
- French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic DocumentationCompletedNCT02874001
- MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast CancerCompletedNCT00462696Not applicable
- Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)CompletedNCT03963518